PHARMACEUTICAL COMPOSITION COMPRISING A SGLT2 INHIBITOR, A DPP-IV INHIBITOR AND OPTIONALLY A FURTHER ANTIDIABETIC AGENT AND USES THEREOF

• 收藏
• 分享

专利权人:

BOEHRINGER INGELHEIM INTERNATIONAL GMBH

发明人:

PETER EICKELMANN,MICHAEL MARK,LEO JOHN SEMAN,LEO THOMAS

申请号：

MYPI 2011003781

公开号：

MY160123A

申请日:

2010.02.11

申请国别(地区):

MY

年份:

2017

代理人:

摘要：

THE INVENTION RELATES TO A PHARMACEUTICAL COMPOSITION ACCORDING TO THE CLAIM 1 COMPRISING AN SGLT2 INHIBITOR, A DPPIV INHIBITOR AND A THIRD ANTIDIABETIC AGENT WHICH IS SUITABLE IN THE TREATMENT OR PREVENTION OF ONE OR MORE CONDITIONS SELECTED FROM TYPE I DIABETES MELLITUS, TYPE 2 DIABETES MELLITUS, IMPAIRED GLUCOSE TOLERANCE AND HYPERGLYCEMIA IN ADDITION THE PRESENT INVENTION RELATES TO METHODS FOR PREVENTING OR TREATING OF METABOLIC DISORDERS AND RELATED CONDITIONS. NO SUITABLE FIGURE

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/